Thursday was departure day for litigation partners at Orrick, Herrington & Sutcliffe, as a pair of four-person groups jumped to new firms. A New York–based quartert headed to Gibson, Dunn & Crutcher, while a Los Angeles–based team moved to Dechert.
According to a Gibson Dunn press release, the new arrivals there are Daniel Thomasch, Richard Mark, Lauren Elliot and Joseph Evall. The press release notes that the four are “known for their work as national lead trial and appellate counsel for Wyeth (now Pfizer) in more than 350 product liability cases involving claims that childhood vaccines containing the preservative thimerosal cause autistic-spectrum disorders in some children.”
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
